Nexus AG (0FGL.L)
EUR 71.3
(1.28%)
EUR 71.3
(1.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 44.98 Million EUR | 14.97% |
| 2022 | 148.9 Million EUR | 10.2% |
| 2021 | 135.12 Million EUR | 8.63% |
| 2020 | 124.38 Million EUR | 7.9% |
| 2019 | 115.27 Million EUR | 12.65% |
| 2018 | 102.33 Million EUR | 12.03% |
| 2017 | 91.34 Million EUR | 8.62% |
| 2016 | 84.09 Million EUR | 8.45% |
| 2015 | 77.54 Million EUR | 27.0% |
| 2014 | 61.06 Million EUR | 7.65% |
| 2013 | 56.72 Million EUR | 12.8% |
| 2012 | 50.28 Million EUR | 14.18% |
| 2011 | 44.04 Million EUR | 34.42% |
| 2010 | 32.76 Million EUR | -3.6% |
| 2009 | 33.98 Million EUR | 545.69% |
| 2008 | 5.26 Million EUR | -79.8% |
| 2007 | 26.05 Million EUR | 13.92% |
| 2006 | 22.86 Million EUR | 56.16% |
| 2005 | 14.64 Million EUR | 4.78% |
| 2004 | 13.97 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 3.39 Million EUR | -26.28% |
| 2024 Q1 | 3.29 Million EUR | -93.28% |
| 2024 Q2 | 4.6 Million EUR | 39.59% |
| 2023 Q1 | 39.9 Million EUR | 0.25% |
| 2023 Q4 | 49.01 Million EUR | 19.65% |
| 2023 FY | 171.2 Million EUR | 14.97% |
| 2023 Q3 | 40.96 Million EUR | -0.84% |
| 2023 Q2 | 41.31 Million EUR | 3.53% |
| 2022 Q2 | 36.56 Million EUR | 0.45% |
| 2022 Q1 | 36.4 Million EUR | 6.65% |
| 2022 Q4 | 39.8 Million EUR | 10.16% |
| 2022 FY | 148.9 Million EUR | 10.2% |
| 2022 Q3 | 36.13 Million EUR | -1.17% |
| 2021 FY | 135.12 Million EUR | 8.63% |
| 2021 Q3 | 33.35 Million EUR | -3.03% |
| 2021 Q2 | 34.39 Million EUR | 3.44% |
| 2021 Q4 | 34.13 Million EUR | 2.34% |
| 2021 Q1 | 33.24 Million EUR | -7.85% |
| 2020 Q1 | 30.3 Million EUR | -6.63% |
| 2020 FY | 124.38 Million EUR | 7.9% |
| 2020 Q4 | 36.08 Million EUR | 26.46% |
| 2020 Q3 | 28.53 Million EUR | -3.18% |
| 2020 Q2 | 29.47 Million EUR | -2.73% |
| 2019 Q4 | 32.45 Million EUR | 12.37% |
| 2019 Q3 | 28.87 Million EUR | 8.22% |
| 2019 Q2 | 26.68 Million EUR | -2.12% |
| 2019 FY | 115.27 Million EUR | 12.65% |
| 2019 Q1 | 27.26 Million EUR | -4.36% |
| 2018 Q3 | 23.96 Million EUR | -6.98% |
| 2018 Q2 | 25.76 Million EUR | 6.91% |
| 2018 Q1 | 24.09 Million EUR | -2.68% |
| 2018 Q4 | 28.5 Million EUR | 18.94% |
| 2018 FY | 102.33 Million EUR | 12.03% |
| 2017 Q1 | 22.25 Million EUR | 1.02% |
| 2017 FY | 91.34 Million EUR | 8.62% |
| 2017 Q2 | 22.27 Million EUR | 0.09% |
| 2017 Q3 | 22.05 Million EUR | -0.97% |
| 2017 Q4 | 24.76 Million EUR | 12.26% |
| 2016 Q1 | 21.3 Million EUR | -0.31% |
| 2016 Q4 | 22.02 Million EUR | 11.01% |
| 2016 Q3 | 19.84 Million EUR | -5.14% |
| 2016 Q2 | 20.91 Million EUR | -1.83% |
| 2016 FY | 84.09 Million EUR | 8.45% |
| 2015 FY | 77.54 Million EUR | 27.0% |
| 2015 Q4 | 21.37 Million EUR | 17.4% |
| 2015 Q3 | 18.2 Million EUR | -7.79% |
| 2015 Q2 | 19.74 Million EUR | 8.36% |
| 2015 Q1 | 18.22 Million EUR | 5.65% |
| 2014 Q4 | 17.24 Million EUR | 19.52% |
| 2014 Q3 | 14.43 Million EUR | -3.02% |
| 2014 Q2 | 14.88 Million EUR | 2.59% |
| 2014 FY | 61.06 Million EUR | 7.65% |
| 2014 Q1 | 14.5 Million EUR | -11.88% |
| 2013 Q3 | 13.78 Million EUR | -0.21% |
| 2013 Q1 | 12.65 Million EUR | -19.49% |
| 2013 FY | 56.72 Million EUR | 12.8% |
| 2013 Q4 | 16.46 Million EUR | 19.4% |
| 2013 Q2 | 13.81 Million EUR | 9.15% |
| 2012 Q1 | 10.69 Million EUR | -12.44% |
| 2012 Q2 | 11.1 Million EUR | 3.86% |
| 2012 Q3 | 11.85 Million EUR | 6.73% |
| 2012 Q4 | 15.72 Million EUR | 32.61% |
| 2012 FY | 50.28 Million EUR | 14.18% |
| 2011 FY | 44.04 Million EUR | 34.42% |
| 2011 Q1 | 8.79 Million EUR | -53.7% |
| 2011 Q4 | 12.21 Million EUR | 7.14% |
| 2011 Q2 | 10.64 Million EUR | 20.94% |
| 2011 Q3 | 11.39 Million EUR | 7.13% |
| 2010 Q2 | 6.52 Million EUR | -17.02% |
| 2010 Q3 | 9.69 Million EUR | 48.53% |
| 2010 Q4 | 19 Million EUR | 96.03% |
| 2010 Q1 | 7.86 Million EUR | -37.54% |
| 2010 FY | 32.76 Million EUR | -3.6% |
| 2009 Q2 | 6.82 Million EUR | -1.7% |
| 2009 Q1 | 6.93 Million EUR | 0.0% |
| 2009 FY | 33.98 Million EUR | 545.69% |
| 2009 Q4 | 12.59 Million EUR | 69.11% |
| 2009 Q3 | 7.44 Million EUR | 9.16% |
| 2008 FY | 5.26 Million EUR | -79.8% |
| 2007 FY | 26.05 Million EUR | 13.92% |
| 2006 FY | 22.86 Million EUR | 56.16% |
| 2005 FY | 14.64 Million EUR | 4.78% |
| 2004 FY | 13.97 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cegedim SA | 235.64 Million EUR | 80.91% |
| Guerbet SA | 550.79 Million EUR | 91.833% |
| Bastide Le Confort Médical SA | 1.91 Million EUR | -2250.313% |
| Revenio Group Oyj | 18.8 Million EUR | -139.282% |
| Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 96.509% |
| Sartorius Aktiengesellschaft | 1.02 Billion EUR | 95.6% |
| LNA Santé SA | 178.1 Million EUR | 74.743% |
| Siemens Healthineers AG | 5.59 Billion EUR | 99.197% |
| Medios AG | 23.03 Million EUR | -95.29% |
| Equasens Société anonyme | 14.67 Million EUR | -206.646% |
| Stratec SE | 41.95 Million EUR | -7.217% |